Market Tracker

08/20 12:32pm ET

Repligen Corp (NASDAQ:RGEN)

20.07
Data as of 12:15pm ET
 -0.30 / -1.47%
Today’s Change
9.41
Today|||52-Week Range
24.68
+47.14%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close20.37
Today’s open20.24
Day’s range19.90 - 20.35
Volume94,340
Average volume (3 months)461,959
Market cap$665.0M
Dividend yield--
Data as of 12:15pm ET, 08/20/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-46.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio40.1
Price/Sales6.34
Price/Book6.26

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc-0.13-0.95%
NLNKNewLink Genetics Cor...-0.51-2.00%
OREXOrexigen Therapeutic...-0.08-1.37%
MACKMerrimack Pharmaceut...-0.01-0.15%
Data as of 12:31pm ET, 08/20/2014

Financials

Last reporting dateAugust 11, 2014
EPS forecast (this quarter)$0.08
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts